New drug duo aims to tackle tough lymphoma in immunocompromised patients
Disease control
Recruiting now
This phase II trial tests whether combining epcoritamab (an immunotherapy that directs immune cells to kill lymphoma) with lenalidomide (which boosts the immune system) can shrink tumors in 34 patients whose immunodeficiency-related large B-cell lymphoma has not responded to trea…
Phase: PHASE2 • Sponsor: Reem Karmali • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC